Corrigendum to: A combination of pterostilbene with autophagy inhibitors exerts efficient apoptotic characteristics in both chemosensitive and chemoresistant lung cancer cells. [Toxicological Sciences, 137, 1, (2014), (65-75)] DOI: 10.1093/toxsci/kft238;A Combination of Pterostilbene With Autophagy Inhibitors Exerts Efficient Apoptotic Characteristics in Both Chemosensitive and Chemoresistant Lung Cancer Cells

Toxicological Sciences

Volumn 137, Issue 1, 2014, Pages 65-75

  Hsieh, Ming Ju ^a,b   Lin, Chiao Wen ^b,c   Yang, Shun Fa ^b,c   Sheu, Gwo Tarng ^b   Yu, Ya Yen ^b,d   Chen, Mu Kuan ^e   Chiou, Hui Ling ^a,b,c  

^a Chang Hua Christian Hospital   (China)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d Chang Hua Hospital   (Taiwan)

^e CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Autophagy; Multidrug resistance; Pterostilbene

Indexed keywords

3 METHYLADENINE; ANTINEOPLASTIC AGENT; BAFILOMYCIN A1; BECLIN 1; DOCETAXEL; PROTEIN KINASE B; PTEROSTILBENE; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; 3-METHYLADENINE; ADENINE; APOPTOSIS REGULATORY PROTEIN; BECN1 PROTEIN, HUMAN; MACROLIDE; MAP1LC3A PROTEIN, HUMAN; MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; STILBENE DERIVATIVE; TAXOID;

APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RESISTANCE; CELL CYCLE ARREST; CELL ORGANELLE; CELL VIABILITY; CHEMOSENSITIVITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; HUMAN; HUMAN CELL; LUNG CANCER; MULTIDRUG RESISTANCE; ANALOGS AND DERIVATIVES; CELL CYCLE CHECKPOINT; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; DRUG RESISTANCE; GENETIC TRANSFECTION; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME; TUMOR CELL LINE;

ADENINE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUNG NEOPLASMS; MACROLIDES; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STILBENES; TAXOIDS; TIME FACTORS; TRANSFECTION;

EID: 84891302858     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfx050     Document Type: Erratum

References (39)

1. Abedin, M. J., Wang, D., McDonnell, M. A., Lehmann, U., and Kelekar, A. (2007). Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ. 14, 500-510.
2. Baird, R. D., and Kaye, S. B. (2003). Drug resistance reversal-are we getting closer? Eur. J. Cancer 39, 2450-2461.
3. Baur, J. A., and Sinclair, D. A. (2006). Therapeutic potential of resveratrol: The in vivo evidence. Nat. Rev. Drug Discov. 5, 493-506.
4. Cecconi, F., and Levine, B. (2008). The role of autophagy in mammalian development: Cell makeover rather than cell death. Dev. Cell 15, 344-357.
5. Chang, C. P., Yang, M. C., Liu, H. S., Lin, Y. S., and Lei, H. Y. (2007). Concanavalin A induces autophagy in hepatoma cells and has a therapeutic effect in a murine in situ hepatoma model. Hepatology 45, 286-296.
6. Chen, R. J., Ho, C. T., and Wang, Y. J. (2010). Pterostilbene induces autophagy and apoptosis in sensitive and chemoresistant human bladder cancer cells. Mol. Nutr. Food Res. 54, 1819-1832.
7. Chen, R. J., Tsai, S. J., Ho, C. T., Pan, M. H., Ho, Y. S., Wu, C. H., and Wang, Y. J. (2012). Chemopreventive effects of pterostilbene on urethane-induced lung carcinogenesis in mice via the inhibition of EGFR-mediated pathways and the induction of apoptosis and autophagy. J. Agric. Food Chem. 60, 11533-11541.
8. Chiu, L. Y., Ko, J. L., Lee, Y. J., Yang, T. Y., Tee, Y. T., and Sheu, G. T. (2010). L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines. Toxicol. Lett. 192, 408-418.
9. Cohen, D., Higman, S. M., Hsu, S. I., and Horwitz, S. B. (1992). The involvement of a LINE-1 element in a DNA rearrangement upstream of the mdr1a gene in a taxol multidrug-resistant murine cell line. J. Biol. Chem. 267, 20248-20254.
10. Davies, A. M., Lara, P. N., Jr, Mack, P. C., and Gandara, D. R. (2003). Docetaxel in non-small cell lung cancer: A review. Expert Opin. Pharmacother. 4, 553-565.
11. Ellington, A. A., Berhow, M. A., and Singletary, K. W. (2006). Inhibition of Akt signaling and enhanced ERK1/2 activity are involved in induction of macroautophagy by triterpenoid B-group soyasaponins in colon cancer cells. Carcinogenesis 27, 298-306.
12. Ferrer, P., Asensi, M., Segarra, R., Ortega, A., Benlloch, M., Obrador, E., Varea, M. T., Asensio, G., Jordá, L., and Estrela, J. M. (2005). Association between pterostilbene and quercetin inhibits metastatic activity of B16 melanoma. Neoplasia 7, 37-47.
13. Finlan, L. E., Kernohan, N. M., Thomson, G., Beattie, P. E., Hupp, T. R., and Ibbotson, S. H. (2005). Differential effects of 5-aminolaevulinic acid photodynamic therapy and psoralen + ultraviolet A therapy on p53 phosphorylation in normal human skin in vivo. Br. J. Dermatol. 153, 1001-1010.
14. Fitzpatrick, F. A., and Wheeler, R. (2003). The immunopharmacology of paclitaxel (Taxol), docetaxel (Taxotere), and related agents. Int. Immunopharmacol. 3, 1699-1714.
15. Fojo, T., and Bates, S. (2003). Strategies for reversing drug resistance. Oncogene 22, 7512-7523.
16. Green, M. R. (2002). Perspectives and opportunities: Docetaxel in the current and future treatment of non-small cell lung cancer. Semin. Oncol. 29(3 Suppl. 12), 17-21.
17. Herman-Antosiewicz, A., Johnson, D. E., and Singh, S. V. (2006). Sulforaphane causes autophagy to inhibit release of cytochrome C and apoptosis in human prostate cancer cells. Cancer Res. 66, 5828-5835.
18. Høyer-Hansen, M., and Jäättelä, M. (2008). Autophagy: An emerging target for cancer therapy. Autophagy 4, 574-580.
19. Hsieh, M. J., Yang, S. F., Hsieh, Y. S., Chen, T. Y., and Chiou, H. L. (2012). Autophagy inhibition enhances apoptosis induced by dioscin in huh7 cells. Evid. Based. Complement. Alternat. Med. 2012, 134512.
20. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., and Thun, M. J. (2009). Cancer statistics, 2009. CA. Cancer J. Clin. 59, 225-249.
21. Kondo, Y., Kanzawa, T., Sawaya, R., and Kondo, S. (2005). The role of autophagy in cancer development and response to therapy. Nat. Rev. Cancer 5, 726-734.
22. Lee, W. S., Chen, R. J., Wang, Y. J., Tseng, H., Jeng, J. H., Lin, S. Y., Liang, Y. C., Chen, C. H., Lin, C. H., Lin, J. K., et al. (2003). In vitro and in vivo studies of the anticancer action of terbinafine in human cancer cell lines: G0/G1 p53-associated cell cycle arrest. Int. J. Cancer 106, 125-137.
23. Longo, L., Platini, F., Scardino, A., Alabiso, O., Vasapollo, G., and Tessitore, L. (2008). Autophagy inhibition enhances anthocyanin-induced apoptosis in hepatocellular carcinoma. Mol. Cancer Ther. 7, 2476-2485.
24. McGrogan, B. T., Gilmartin, B., Carney, D. N., and McCann, A. (2008). Taxanes, microtubules and chemoresistant breast cancer. Biochim. Biophys. Acta 1785, 96-132.
25. Opipari, A. W. Jr, Tan, L., Boitano, A. E., Sorenson, D. R., Aurora, A., and Liu, J. R. (2004). Resveratrol-induced autophagocytosis in ovarian cancer cells. Cancer Res. 64, 696-703.
26. Pan, M. H., Chang, Y. H., Badmaev, V., Nagabhushanam, K., and Ho, C. T. (2007). Pterostilbene induces apoptosis and cell cycle arrest in human gastric carcinoma cells. J. Agric. Food Chem. 55, 7777-7785.
27. Remsberg, C. M., Yáñez, J. A., Ohgami, Y., Vega-Villa, K. R., Rimando, A. M., and Davies, N. M. (2008). Pharmacometrics of pterostilbene: Preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity. Phytother. Res. 22, 169-179.
28. Rimando, A. M., Cuendet, M., Desmarchelier, C., Mehta, R. G., Pezzuto, J. M., and Duke, S. O. (2002). Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol. J. Agric. Food Chem. 50, 3453-3457.
29. Rosenfeldt, M. T., and Ryan, K. M. (2009). The role of autophagy in tumour development and cancer therapy. Expert Rev. Mol. Med. 11, e36.
30. Scarlatti, F., Maffei, R., Beau, I., Codogno, P., and Ghidoni, R. (2008). Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells. Cell Death Differ. 15, 1318-1329.
31. Shacka, J. J., Klocke, B. J., Shibata, M., Uchiyama, Y., Datta, G., Schmidt, R. E., and Roth, K. A. (2006). Bafilomycin A1 inhibits chloroquineinduced death of cerebellar granule neurons. Mol. Pharmacol. 69, 1125-1136.
32. Shintani, T., and Klionsky, D. J. (2004). Autophagy in health and disease: A double-edged sword. Science 306, 990-995.
33. Stivala, L. A., Savio, M., Carafoli, F., Perucca, P., Bianchi, L., Maga, G., Forti, L., Pagnoni, U. M., Albini, A., Prosperi, E., et al. (2001). Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J. Biol. Chem. 276, 22586-22594.
34. Thorburn, A. (2008). Apoptosis and autophagy: Regulatory connections between two supposedly different processes. Apoptosis 13, 1-9.
35. Tolomeo, M., Grimaudo, S., Di Cristina, A., Roberti, M., Pizzirani, D., Meli, M., Dusonchet, L., Gebbia, N., Abbadessa, V., Crosta, L., et al. (2005). Pterostilbene and 3'-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells. Int. J. Biochem. Cell Biol. 37, 1709-1726.
36. White, R. J. (1997). Regulation of RNA polymerases I and III by the retinoblastoma protein: A mechanism for growth control? Trends Biochem. Sci. 22, 77-80.
37. Wong, R. W., and Rabie, A. B. (2011). Effect of psoralen on bone formation. J. Orthop. Res. 29, 158-164.
38. Yang, Y. P., Liang, Z. Q., Gu, Z. L., Qin, Z. H. (2005). Molecular mechanism and regulation of autophagy. Acta Pharmacol Sin. 26, 1421-1434.
39. Zhang, X. D., Wang, Y., Wang, Y., Zhang, X., Han, R., Wu, J. C., Liang, Z. Q., Gu, Z. L., Han, F., Fukunaga, K., et al. (2009). p53 mediates mitochondria dysfunction-triggered autophagy activation and cell death in rat striatum. Autophagy 5, 339-350.